A possible silver lining for Australia's biotech innovators after bombshell Myriad decision

A possible silver lining for Australia's biotech innovators after bombshell Myriad decision

IP owners everywhere are well aware that a ruling on patent eligibility from a country’s highest court can turn a market on its head overnight. As IAM has detailed in the past, the extent to which an IP office offers well-defined guidance on those…

Unlock unlimited access to all IAM content